MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Venture Capital: *Investment Round
Venture Capital: Series D
Cagent Vascular
Organization & Developments: Cagent Vascular
Parents
Cagent Vascular
Children
*Cagent Vascular pioneers Serration Remodeling Therapy (SRT), a novel approach to vessel preparation that gently remodels the artery to reduce recoil, optimize lumen gain, and support durable outcomes.
*Cagent’s Serranator Sonic IVL system brings together its Serranator serration remodeling therapy (SRT) and the Sonic lithotripsy generator.
*Intravascular technology to treat diseased peripheral arteries.
*Technology is minimally invasive device for vessel dilatation
2026: Cagent Vascular reports first-in-human IVL cases, closes $41M Series D
2026: U.S. Venture Partners (USVP) and Astoria Health Investors provided funding for the $41 million funding round
Serration Remodeling Therapy (SRT)
Jumps
Finance & Acquisitions: Cagent Vascular
Key People: Cagent Vascular